Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas

by Debra Nana Yeboa, James B. Yu, Eric Liao, Jason Huse, Marta Penas-Prado, Benjamin H. Kann, Erik Sulman, David Grosshans, Joseph Contessa
Published 2019-02-01

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

by Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon
Published 2020-07-01

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy

by Guangyang Yu, Madison K. Butler, Abdalla Abdelmaksoud, Ying Pang, Yu-Ting Su, Zachary Rae, Kimia Dadkhah, Michael C. Kelly, Young K. Song, Jun S. Wei, Masaki Terabe, Ramya Atony, Kelly Mentges, Brett J. Theeler, Marta Penas-Prado, John Butman, Kevin Camphausen, Kareem A. Zaghloul, Edjah Nduom, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, Mark R. Gilbert, James L. Gulley, Javed Khan, Jing Wu
Published 2021-01-01